Huang, Qi-Fang
Zhang, Di
Luo, Yihong
Hu, Kun
Wu, Qiong
Qiu, Hailong
Xu, Fei
Wang, Mei-Ling
Chen, Xin
Li, Yan
Wang, Ji-Guang http://orcid.org/0000-0001-8511-1524
,
Funding for this research was provided by:
Di’ao Pharmaceuticals
National Natural Science Foundation of China (82370426, 82270469, 82070432, 81970353)
Ministry of Science and Technology, Beijing, China (2022YFC3601302)
Shanghai Municipal Health Commission (202340035, 2022LJ022)
Article History
Received: 31 July 2023
Accepted: 28 December 2023
First Online: 24 January 2024
Declarations
:
: The study protocol was approved by the ethics committee of Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (2018–45). The patients/participants provided their written informed consent to participate in this study.
: Not applicable.
: The authors declare that they have no competing interests.